ACS
STJ

Archford Capital Strategies’s St Jude Medical STJ Stock Holding History

Archford Capital Strategies’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-292
Closed -$18K – 865
2015
Q3 		$18K Hold
292
– – 0.01% 290
2015
Q2 		$21K Hold
292
– – 0.02% 272
2015
Q1 		$19.1K Sell
292
-12,281
-98% -$817K 0.01% 289
2014
Q4 		$818K Buy
12,573
+125
+1% +$8.05K 0.6% 55
2014
Q3 		$748K Buy
+12,448
New +$813K 0.59% 54

Other funds holding STJ

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Archford Capital Strategies's STJ Position: Q4 2015 in Review

Archford Capital Strategies sold out of St Jude Medical (STJ) in Q4 2015, closing a stake of 292 shares — an estimated $18K sold.

Archford Capital Strategies first reported a position in STJ in Q3 2014 and held it in 5 quarters. The position peaked at $818K in Q4 2014. 620 funds tracked by Wall St. Rank hold STJ as of Q4 2015.

  • Archford Capital Strategies reported no remaining St Jude Medical position as of Q4 2015 after selling out during the quarter.
  • Archford Capital Strategies sold 292 St Jude Medical shares in Q4 2015, an estimated $18K.
  • Archford Capital Strategies first reported a position in St Jude Medical in Q3 2014 and held it in 5 quarters.
  • Archford Capital Strategies's St Jude Medical position peaked at $818K in Q4 2014.
  • 620 funds tracked by Wall St. Rank held St Jude Medical as of Q4 2015.

Based on Archford Capital Strategies's 13F filing for Q4 2015, filed 11 Feb 2016.